Balaxi Pharmaceuticals Ltd

NSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Balaxi Pharmaceuticals Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
Near 52W High of ₹686.30
4.8
TTM PE Ratio
Negative PE TTM
-138.4
Price to Book Ratio
Above industry Median
4
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is much higher than 1
1.3
RSI
RSI is mid-range
66.4
MFI
MFI is mid-range
64

Balaxi Pharmaceuticals Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Balaxi Pharmaceuticals Ltd shareholding Pattern

Promoter
66.9%
Foreign Institutions
17.2%
Public
15.9%
Promoter
71.2%
Foreign Institutions
18.6%
Public
10.2%
Promoter
71.2%
Foreign Institutions
18.6%
Public
10.2%
Promoter
71.2%
Foreign Institutions
18.6%
Public
10.2%
Promoter
71.6%
Foreign Institutions
18.7%
Public
9.7%
Promoter
72.7%
Foreign Institutions
19%
Public
8.3%

Balaxi Pharmaceuticals Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
644.70
10Day EMA
630.70
12Day EMA
626.30
20Day EMA
612.10
26Day EMA
603.80
50Day EMA
578.80
100Day EMA
544.90
200Day EMA
519.50
5Day SMA
644.40
10Day SMA
623.80
20Day SMA
606.90
30Day SMA
596.20
50Day SMA
564.50
100Day SMA
530.30
150Day SMA
494.80
200Day SMA
487.00
Delivery & Volume
Resistance & Support
644.18
Pivot
Resistance
First Resistance
672.17
Second Resistance
689.73
Third Resistance
717.72
Support
First Support
626.62
Second support
598.63
Third Support
581.07
Relative Strength Index
66.41
Money Flow Index
64.04
MACD
22.49
MACD Signal
18.03
Average True Range
31.01
Average Directional Index
31.71
Rate of Change (21)
12.90
Rate of Change (125)
59.70
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Sakuma Exports Ltd.
855.97
12.53
30.75
Vinyl Chemicals (I) Ltd.
675.72
311.4
545.95
Black Rose Industries Ltd.
-
-
-
Remedium Lifecare Ltd.
-
-
-
Tinna Trade Ltd.
-
-
-
Shankar Lal Rampal Dye-Chem Ltd.
-
-
-

Balaxi Pharmaceuticals Ltd Company background

Founded in: 1942
Balaxi Ventures Limited (erstwhile known as The Anandam Rubber Company Limited) is a public limited company incorporated in India in September 28, 1942 with a basic objective of running rubber and tea plantations and owns several plantations across South India. In the year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading. The company previously was a investment company, but the company during the financial year 201819 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products Securities and Exchange Board of India (SEBI) vide Circular dated May 30, 2012 had issued revised Exit Policy for derecognized/nonoperational stock exchanges. Pursuant to the circular, Madras Stock Exchange has been derecognized by SEBI, recently. Further, as per above cited circular issued by SEBI on May 30, 2012, and Public Notice issued by Madras Stock Exchange Limited (MSE), it cleared that the Exclusively Listed Companies, which fail to obtain listing on any other stock exchange, will cease to be a listed company and will be moved to the Dissemination Board by the exiting stock exchange. Also, it is to be noted that SEBI has given a time limit of eighteen months for getting listed with any of the recognized stock exchanges. In pursuance to the above notice, the company has submitted listing application with National Stock Exchange of India (NSE) Limited on 19th January 2015 under listing criteria for Exclusively Listed Companies. The submitted listing application is under process with the National Stock Exchange of India (NSE) Limited and the company is hoping to be get listed very soon. Madras Stock Exchange has intimated the Company that it has been placed before Dissemination Board (DB) of National Stock Exchange of India (NSE) Limited. Under the Dissemination Board mechanism, a willing buyer and seller will be given an opportunity to disseminate their offers using the services of brokers of stock exchanges hosting Dissemination Board. On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.e. Mr. Nirej V. Paul, Mr. V. M. Paulose, Dr. Leelamma T. J and Mrs. Jaya Paul) to acquire 1,670,036 Equity Shares representing 54.94% of the paid up share capital of the Company along with the control over the Company, pursuant to which BOPL made an Open Offer under Regulation 3(1) and Regulation 4 of SEBI (SAST) Regulations, 2011. Control and management of the Company was acquired by BOPL on May 04, 2017 and it became the new promoter of Company and their representatives i.e. Mr. Ashish Maheshwari and Mrs. Minoshi Maheshwari became the new Directors of the Company. Simultaneously, erstwhile promoters stepped down as promoters from Company on same day and Mr. Nirej V. Paul and Dr. Leelamma TJ resigned as Managing Director and as Chairperson from the Company, respectively. Under the above said Open Offer, BOPL acquired 3,30,000 equity shares representing 10.86% equity share capital of the Company. On completion of the Open Offer BOPL became the holding and Promoter Company with an aggregate shareholding of 2000036 Equity Shares (ie 65.79%).The Company changed its name from The Anandam Rubber Company Limited to Balaxi Ventures Limited through Postal Ballot passed on August 08, 2017. It had also changed the Registered Office from 41/298 D2, 2nd Floor, Saniya Plaza, Mahakavi Bharathiyar Road, Near KSRTC Bus Stand, Cochin 682035 to Plot No.409, H.No. 82293, MAPS Towers, 3rd Floor, PhaseIII, Road No.81, Jubilee Hills, Hyderabad, Telangana, India 500096 through Postal Ballot passed on August 08, 2017.The main objects of the company were amended to include activities of International wholesale trading in pharmaceutical, food products and builders hardware by way of a Postal Ballot passed on August 08, 2018. The Company commenced the business of international wholesale trading in pharmaceuticals and builders hardware products starting September 2018. Further, in February 2019, The Company decided to kickstart its Food Products business by launching a range of biscuits under the brand YAP.The Board of the company approved the proposed preferential issue of 69,60,000 Equity shares on June 19, 2019 and subsequently obtained shareholders approval on July 12, 2019 via Extra Ordinary General Meeting. The Company had obtained required approvals from stock exchange and allotted 69,60,000 Equity shares on preferential basis on August 09, 2019. Consequently, the Paid up share capital of the company has been accordingly increased from Rs 3,04,00,000/ consisting of 30,40,000 Equity shares of Rs 10/ each to Rs 10,00,00,000/ consisting of 1,00,00,000 Equity shares of Rs 10/ each.
Read More

Balaxi Pharmaceuticals Ltd FAQs

The past 1-year return of Balaxi Pharmaceuticals Ltd [BALAXI] share was 18.05. The Balaxi Pharmaceuticals Ltd [BALAXI] share hit a 1-year low of Rs. 399.95 and a 1-year high of Rs. 686.3.

The market cap of Balaxi Pharmaceuticals Ltd is Rs. 713.37 Cr. as of 5/17/2024 12:00:00 AM.

The PE ratios of Balaxi Pharmaceuticals Ltd is 87.28 as of 5/17/2024 12:00:00 AM.

The PB ratios of Balaxi Pharmaceuticals Ltd is 5.59 as of 5/17/2024 12:00:00 AM

You can easily buy Balaxi Pharmaceuticals Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage